Intranasal monkeypox marmoset model: Prophylactic antibody treatment provides benefit against severe monkeypox virus disease.

about

Intranasal monkeypox marmoset model: Prophylactic antibody treatment provides benefit against severe monkeypox virus disease.

Item

http://www.wikidata.org/entity/Q55714396

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Intranasal monkeypox marmoset ...... evere monkeypox virus disease.

@en

Intranasal monkeypox marmoset ...... evere monkeypox virus disease.

@nl

type

Item

label

Intranasal monkeypox marmoset ...... evere monkeypox virus disease.

@en

Intranasal monkeypox marmoset ...... evere monkeypox virus disease.

@nl

prefLabel

Intranasal monkeypox marmoset ...... evere monkeypox virus disease.

@en

Intranasal monkeypox marmoset ...... evere monkeypox virus disease.

@nl

P1476

Intranasal monkeypox marmoset ...... severe monkeypox virus disease

@en

P2093

Adrienne Kimmel

http://www.w3.org/2001/XMLSchema#string

Darryl Sampey

http://www.w3.org/2001/XMLSchema#string

Jay W Hooper

http://www.w3.org/2001/XMLSchema#string

Josh Shamblin

http://www.w3.org/2001/XMLSchema#string

P2860

Side-by-side comparison of gene-based smallpox vaccine with MVA in nonhuman primates

Structural basis for the binding of the neutralizing antibody, 7D11, to the poxvirus L1 protein

Gender effects on humoral immune responses to smallpox vaccine.

Control of vaccinia virus skin lesions by long-term-maintained IFN-gamma+TNF-alpha+ effector/memory CD4+ lymphocytes in humans.

Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge

Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo.

Chimpanzee/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virus.

Smallpox vaccine safety is dependent on T cells and not B cells

Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults.

Susceptibility of Marmosets (Callithrix jacchus) to Monkeypox Virus: A Low Dose Prospective Model for Monkeypox and Smallpox Disease.

P304

e0006581

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PNTD.0006581

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Suzanne E Wollen-Roberts

Eric M Mucker

P577

2018-06-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29927927

http://www.w3.org/2001/XMLSchema#string

P932

6029809

http://www.w3.org/2001/XMLSchema#string